Tom participated in a two year study that closed in December of 2025, and did not hesitate when another study arose. He knows that even if the medication may not be helping him, it is helping the next generation have a better fight than his generation against the disease Tom is willing to go above and beyond when it comes to helping the next generation with a willingness to continue pursuing research even if studies end.
Tom Baldwin
